Loss Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The loss ratio is calculated by taking the incurred underwriting losses and then dividing them by earned premium. Calculated as: Underwriting Losses Total / Net Premiums Earned
Ultragenyx Pharmaceutical Inc. (RARE) Loss Ratio data is not available.
| Income Statement Financials | |
$207.28M |
|
$-128.56M |
|
$29.34M |
|
$177.93M |
|
$320.56M |
|
$-113.28M |
|
$-14.40M |
|
$-127.69M |
|
$-127.69M |
|
$-128.56M |
|
$-128.56M |
|
$-128.56M |
|
$-128.56M |
|
$-113.28M |
|
$-105.01M |
|
98.60M |
|
98.60M |
|
$-1.28 |
|
$-1.28 |
|
| Balance Sheet Financials | |
$951.00M |
|
$244.00M |
|
$581.00M |
|
$1.53B |
|
$384.00M |
|
-- |
|
$1.23B |
|
$1.61B |
|
$-80.00M |
|
$-300.00M |
|
$-80.00M |
|
96.60M |
|
| Cash Flow Statement Financials | |
$-466.00M |
|
$236.00M |
|
$478.00M |
|
$184.00M |
|
$436.00M |
|
$252.00M |
|
$153.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
85.84% |
|
-54.65% |
|
-54.65% |
|
-- |
|
-61.60% |
|
-62.02% |
|
$-472.00M |
|
|
Loss Ratio |
-- |
-- |
|
-- |
|
0.14 |
|
0.56 |
|
1.31 |
|
68.60 |
|
160.69% |
|
42.85% |
|
-8.39% |
|
160.69% |
|
$-0.83 |
|
$-4.79 |
|
$-4.73 |
|